Ascenta Therapeutics' Series A Round

Ascenta Therapeutics raised a round of funding on December 19, 2003.

Ascenta Therapeutics is a privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. Ascenta's current focus is a portfolio …

Articles about Ascenta Therapeutics' Series A Round: